DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Taxonomy: TH- Radiobiology(RBio)/Biology(Bio): RBio- Photons
| MO-C930-GePD-F1-3 | Using Gold Nano Particles (GNPs) as a Radiation Sensitizer - A Monte Carlo Simulation Y Chiang*, C Lee , T Chao , Chang Gung University, Guishan Dist, TAO |
| MO-J430-CAMPUS-F3-1 | Radiobiological Modeling of the Temporal Behavior of PSA for Low-Risk Prostate Cancer Patients Treated with Moderately Hypo-Fractionated IMRT Alone R Pino1*, J Grandinetti2 , E Rodriguez1 , W Mai3 , EB Butler1 , BS Teh1 , (1) Houston Methodist Hospital, Houston, TX, (2) UT Southwestern, Dallas, TX, (3) Baylor College of Medicine, Houston, TX |
| PO-GePV-T-47 | Optimization of Irradiation Interval for Fractionated Stereotactic Radiosurgery by An Improved Cellular Automata Model D Kawahara1*, Lin WU2 , Y Watanabe2 , (1) Hiroshima University, Hiroshima, Japan,(2) University of Minnesota, Minneapolis, MN |
| PO-GePV-T-402 | Cascade BED: A Supra-Heterogeneous Dose Distribution for Lung SBRT D Pokhrel*, L Sanford , University of Kentucky, Lexington, KY |
| SU-J400-CAMPUS-F3-4 | The Magic of Spatially Fractionated Radiation S Chang1*, (1) UNC School of Medicine, Chapel Hill, NC |
| TH-BC-SAN1-0 | Rationale and Evidence for SBRT V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-BC-SAN1-1 | Introduction V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-BC-SAN1-2 | Radiation Therapy Dose Response Modeling and Optimization of Fractionation Schedules with Cancer Stem Cells V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-BC-SAN1-3 | Role of Vascular Damage and Tumor Microenvironment in the Response of Tumors to SBRT and SRS V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-BC-SAN1-4 | Biological Dose Escalation and Outcomes Modeling in the Era of Stereotactic Radiotherapy V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-BC-SAN1-5 | Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-BC-SAN1-6 | Q&A V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY |
